Literature DB >> 19083

The isolation and characterization of sphingomyelinase from human placental tissue.

P G Pentchev, R O Brady, A E Gal, S R Hibbert.   

Abstract

Human placental sphingomyelinase activity was eluted as a single symmetrical peak from Sephadex G-200 with a molecular weight of 290000; however, the enzyme behaved heterogeneously on ion exchange chromatography. A specific species of sphingomyelinase was purified approx. 10 000-fold to a constant specific activity of 274 000 nanomol of sphingomyelin hydrolyzed per mg protein per h. When the purified enzyme was examined on sodium dodecyl sulfate disc gel electrophoresis, two distinct protein bands in approximately equal proportions with molecular weights of 36 800 and 28 300 were found. The specificity of the enzyme is directed towards both the hydrophilic phosphocholine and the hydrophobic ceramide moieties of sphingomyelin. Possible interrelationships between the heterogenous forms of placental sphingomyelinases are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19083     DOI: 10.1016/0005-2760(77)90189-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status.

Authors:  K Suzuki
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

2.  Studies on the hydrophobic properties of sphingomyelinase.

Authors:  J W Callahan; J Gerrie; C S Jones; P Shankaran
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

3.  Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography.

Authors:  C S Jones; P Shankaran; J W Callahan
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

4.  Studies on the structure of sphingomyelinase. Amino acid composition and heterogeneity on isoelectric focusing.

Authors:  C S Jones; P Shankaran; D J Davidson; A Poulos; J W Callahan
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

5.  Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.

Authors:  P G Pentchev; B Neumeyer; L Svennerholm; C G Groth; R O Brady
Journal:  Am J Hum Genet       Date:  1983-07       Impact factor: 11.025

6.  Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent ceramide analogue.

Authors:  N G Lipsky; R E Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B.

Authors:  C Rodriguez-Lafrasse; M T Vanier
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

8.  The hydrolysis of phosphatidylinositol by lysosomal enzymes of rat liver and brain.

Authors:  R F Irvine; N Hemington; R M Dawson
Journal:  Biochem J       Date:  1978-11-15       Impact factor: 3.857

9.  Deficiency of taurocholate-dependent phospholipase C acting on phosphatidylcholine in Niemann-Pick disease.

Authors:  J R Wherrett; S Huterer
Journal:  Neurochem Res       Date:  1983-01       Impact factor: 3.996

10.  Niemann-Pick disease type C. Pathological, histochemical, ultrastructural and biochemical studies.

Authors:  E F Gilbert; J Callahan; C Viseskul; J M Opitz
Journal:  Eur J Pediatr       Date:  1981-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.